On November 10, Thermo Fisher Scientific rose 3.06% in Regular Trading, trading at $716.34 per share, with turnover of $638 million.

The move was accompanied by the company’s newly authorized share repurchase plan of up to $5 billion, which replaces the prior authorization that had about $1 billion remaining, while the quarterly dividend was maintained at $0.47 per share.

Background figures also show Thermo Fisher Scientific reported third-quarter adjusted EPS of $6.68 on revenue of $12.14 billion, both above market expectations. The combination of better-than-expected results and a larger buyback authorization reinforced investor confidence in cash generation and longer-term capital return.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)